Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPA in Colonic Polyps
NCT00432913Phase 3Completed
- Sponsor
- SLA Pharma
- Start
- Oct 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of eicosapentaenoic acid in adenomatous polyp, sponsored by SLA Pharma. Started Oct 2006; status: completed.
02
Drugs
eicosapentaenoic acid
03
Conditions
adenomatous polyp
Beyond the preview
Go deeper on NCT00432913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432913.